alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheets and consolidated statements of income from the June
30, 1998 Form 10-Q Report and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                       3,842,000
<SECURITIES>                                         0
<RECEIVABLES>                                2,416,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             6,258,000
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             141,716,000
<CURRENT-LIABILITIES>                       11,871,000
<BONDS>                                     11,750,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       321,000
<OTHER-SE>                                  86,579,000
<TOTAL-LIABILITY-AND-EQUITY>               141,716,000
<SALES>                                              0
<TOTAL-REVENUES>                             4,739,000
<CGS>                                                0
<TOTAL-COSTS>                                1,884,000
<OTHER-EXPENSES>                             2,113,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             474,000
<INCOME-PRETAX>                                268,000
<INCOME-TAX>                                   116,000
<INCOME-CONTINUING>                            152,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   152,000
<EPS-PRIMARY>                                      .01
<EPS-DILUTED>                                      .01
        

</TABLE>
Exhibit 35.1



Servicer Compliance Statement of AmeriCredit Financial Services,
Inc.



This Annual Statement as to Compliance is delivered
to you pursuant to Section 4.10 (a) of the Sale and Servicing Agreement dated as of April 22, 2020 (the “Agreement”) and Item
1123 of Regulation AB, executed in connection with the formation of GM Financial Consumer Automobile Receivables Trust 2020-2 (the “Trust”),
the issuance of the Notes by the Trust and the closing of the transactions and the execution and delivery of the various documents by
AmeriCredit Financial Services, Inc. (the “Servicer”) and AFS SenSub Corp. in connection therewith. The capitalized terms
used herein shall have the same meanings as in the Agreement.



The undersigned certifies
that I am the Executive Vice President, Corporate Controller and Chief Accounting Officer of the Servicer. I further certify as follows:



| | 1. | I have conducted, or caused to be conducted under my supervision, a review of the Servicer during the
preceding period from January 1, 2021 through December 31, 2021, and its performance under the Agreement.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To the best of my knowledge, following such review, the Servicer has fulfilled all its obligations under
the Agreement throughout such period, and, to the best of my knowledge, there has been no default in the fulfillment of any such obligation.
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|AmeriCredit Financial Services, Inc. |                                         | 
|------------------------------------ | --------------------------------------- | 
|                                     |                                         | 
|By:                                  | /s/ Connie Coffey                       | 
|                                     | Connie Coffey                           | 
|                                     | Executive Vice President, Corporate     | 
|                                     | Controller and Chief Accounting Officer |
###### Editorial Note on Part 1

#### Editorial Notes:

1. In Patent and Trademark Office publications and usage the part number is omitted from the numbers of §§ 1.1 to 1.352 and the numbers to the right of the decimal point correspond with the respective rule numbers.

2. For nomenclature changes to part 1, see 68 FR 14335, Mar. 25, 2003; 87 FR 68904, Nov. 17, 2022.

#### § 1.730 Applicant for extension of patent term; signature requirements.

(a) Any application for extension of a patent term must be submitted by the owner of record of the patent or its agent and must comply with the requirements of § 1.740.

(b) If the application is submitted by the patent owner, the application must be signed either by:

(1) The patent owner in compliance with § 3.73(c) of this chapter; or

(2) A registered practitioner on behalf of the patent owner.

(c) If the application is submitted on behalf of the patent owner by an agent of the patent owner (e.g., a licensee of the patent owner), the application must be signed by a registered practitioner on behalf of the agent. The Office may require proof that the agent is authorized to act on behalf of the patent owner.

(d) If the application is signed by a registered practitioner, the Office may require proof that the practitioner is authorized to act on behalf of the patent owner or agent of the patent owner.

[65 FR 54679, Sept. 8, 2000, as amended at 77 FR 48825, Aug. 14, 2012]

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.
## In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02

- 18

- 00191

- CV

I N THE I NTEREST OF K.S. AND E.S.,

C HILDREN §

§

§

§ On Appeal from the 235th District

Court

of Cooke County (CV17

- 00339)

September 2 8 , 2018

Opinion by Justice Meier

J UDGMENT

This court has considered the record on appeal in this case and holds that there

was no error in the trial court’s judgment. It is ordered that the judgment of the trial

court is affirmed.

SECOND DISTRICT COURT OF APPEALS

By /s/ Bill Meier

Justice Bill Meier
§ 600.400 Basis, scope, and applicability. ( a ) *Statutory basis.* This subpart implements sections 1331(b), (c), and (g) of the Affordable Care Act, which set forth provisions regarding the minimum coverage standards under BHP, as well as the delivery of such coverage, including the contracting process for standard health plan offerors participating in the BHP.
( b ) *Scope and applicability.* This subpart consists of provisions relating to all BHPs for the delivery of, at a minimum, the ten essential health benefits as described in section 1302(b) of the Affordable Care Act, the contracting process by which States must contract for the provision of standard health plans, the minimum requirements States must include in their standard health plan contracts, the minimum coverage standards provided by the standard health plan offeror, and other applicable requirements to enhance the coordination of the provision of standard health plan coverage.
12/17/2014 Page of

POST FOCUS REVIEW EXPOSURE REPORT

 

Chemical ID: P-15-0001 Reviewer: Tobas/BC 

 

 

Results Table: Dose, Concentration, and Days Exceeded Results Summary

Exposure Scenario1 Water Landfill Stack Air Fugitive Air

Release activity(ies)2; 

exposure calculation(s)3

Drinking Water Fish Ingestion 7Q104 

CC =18

PDM 

Days 

Exceeded

LADD ADR LADD ADR LADD

ADR LADD ADR LADD 

mg/kg/day mg/kg/day mg/kg/day mg/kg/day μg/l # Days mg/kg/day mg/kg/day mg/kg/day mg/kg/day mg/kg/day

max acute eco --- --- --- --- 1.48E+00 --- --- --- --- --- ---

1 Exposure scenario titles consist of release activity followed by exposure calculation abbreviation. 2 Release activities are from engineering report's Manufacturing (Mfg), Processing (Proc) and Use release activity labels.

 Multiple release activities are combined in one exposure scenario if their releases occur at same location. 3 Exposure calculations are Acute Dose Rate (ADR), Lifetime Average Daily Dose (LADD), and Probabilistic Dilution 

 Model (PDM). There may be one, two, or all three exposure calculations per exposure scenario.

 CC is the aquatic concentration of concern. 4 This column displays concentration values for the 7Q10 streamflow, which is defined as the average daily streamflow 

 of the seven consecutive days of lowest flow within a ten year period.

Remarks: 
12/17/2014 Page of

 POST FOCUS REVIEW EXPOSURE REPORT

Chemical ID: P-15-0001 Assessor: Tobas/BC

ENVIRONMENTAL RELEASES

Scenario#:1 Number of Release Sites: 

Release Activity: Max ADR

Release Description: WATER LANDFILL

Non-sludge/Sludge 

STACK FUGITIVE

Total Releases:

(kg/yr) (kg/yr) (kg/yr) (kg/yr)

Non-sludge/Sludge

Release Days/yr:

Per Site Release:

(kg/site/day) (kg/site/day) (kg/site/day) (kg/site/day)

Remarks: 
12/17/2014 Page of

POST FOCUS REVIEW EXPOSURE REPORT

Chemical ID: P-15-0001

SITE-SPECIFIC HUMAN AND AQUATIC EXPOSURES TO SURFACE WATER RELEASES

SCENARIO NUMBER:1 RELEASE ACTIVITY: Max ADR

FACILITY NAME: 

FACILITY LOCATION: 

RECEIVING WATER NAME: 

REACH NUMBER: FACILITY ON REACH: DISCHARGE TYPE: 

NPDES PERMIT #: EXPOSED POPULATION: Adult

WWT 

REMOVAL

(%)

RELEASE

DAYS

PRETREATMENT 

RELEASE 

(kg/site/day)

POSTTREATMENT 

RELEASE 

(kg/site/day)

DWT

(%) BCF

(L/kg)

 0.00 0.00

AQUATIC EXPOSURE ESTIMATES - SURFACE WATER

FLOW DESCRIPTOR Harmonic Mean 30Q5 7Q10 1Q10 PLANT

FLOW (MLD)

CONCENTRATION (μg/L) 0.51 0.97 1.48 1.81 NA

DRINKING WATER INGESTION AND FISH INGESTION EXPOSURE ESTIMATES

Exposure Units

Drinking Water 

Results

Drinking Water 

Units

Fish Ingestion 

Results

Fish Ingestion 

Units

Cancer

LADDpot 6.13E-08 mg/kg/day 0.00 mg/kg/day

LADCpot 4.72E-06 mg/L 0.00 mg/kg

Acute

ADRpot 3.67E-05 mg/kg/day 0.00 mg/kg/day

Surface Water Comments:
§ 88.3 Eligibility—currently identified responders. ( a ) Responders who were identified as eligible for monitoring and treatment under the arrangements as in effect on January 2, 2011, between NIOSH and the consortium administered by Mount Sinai School of Medicine in New York City and the Fire Department, City of New York, are enrolled in the WTC Health Program. ( 1 ) No individual who is determined to be a positive match to the terrorist watch list maintained by the Federal government will be considered to be enrolled in the WTC Health Program.
( 2 ) [Reserved]
( b ) WTC responders identified as enrolled under this section are not required to submit an application to the WTC Health Program.
###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

###### Editorial Note on Subchapter A of Chapter I

#### Editorial Note:

Part 5 is placed in the separate grouping of parts pertaining to patents regulations.

#### § 11.114 Client with diminished capacity.

(a) When a client's capacity to make adequately considered decisions in connection with a representation is diminished, whether because of minority, mental impairment or for some other reason, the practitioner shall, as far as reasonably possible, maintain a normal client-practitioner relationship with the client.

(b) When the practitioner reasonably believes that the client has diminished capacity, is at risk of substantial physical, financial or other harm unless action is taken and cannot adequately act in the client's own interest, the practitioner may take reasonably necessary protective action, including consulting with individuals or entities that have the ability to take action to protect the client and, in appropriate cases, seeking the appointment of a guardian ad litem, conservator or guardian.

(c) Information relating to the representation of a client with diminished capacity is protected under § 11.106. When taking protective action pursuant to paragraph (b) of this section, the practitioner is impliedly authorized under § 11.106(a) to reveal information about the client, but only to the extent reasonably necessary to protect the client's interests.
§ 82.0 Background information on this part. The Energy Employees Occupational Illness Compensation Program Act (EEOICPA), 42 U.S.C. 7384-7385 [1994, supp. 2001], provides for the payment of compensation benefits to covered employees and, where applicable, survivors of such employees, of the United States Department of Energy (“DOE”), its predecessor agencies and certain of its contractors and subcontractors. Among the types of illnesses for which compensation may be provided are cancers. There are two categories of covered employees with cancer under EEOICPA for whom compensation may be provided. The regulations that follow under this part apply only to the category of employees described under paragraph (a) of this section. ( a ) One category is employees with cancer for whom a dose reconstruction must be conducted, as required under 20 CFR 30.115.
( b ) The second category is members of the Special Exposure Cohort seeking compensation for a specified cancer, as defined under EEOICPA. The U.S. Department of Labor (DOL) which has primary authority for implementing EEOICPA, has promulgated regulations at 20 CFR 30.210 and 30.213 that identify current members of the Special Exposure Cohort and requirements for compensation. Pursuant to section 3626 of EEOICPA, the Secretary of HHS is authorized to add additional classes of employees to the Special Exposure Cohort.
#define binary_width 20#define binary_height 23static char binary_bits[] = {   0x00, 0x00, 0x00, 0x00, 0x00, 0x00, 0xff, 0x3f, 0x00, 0x01, 0x60, 0x00,   0x01, 0xa0, 0x00, 0x71, 0x26, 0x01, 0xd9, 0x26, 0x02, 0xd9, 0xe6, 0x07,   0xd9, 0xc6, 0x0f, 0xd9, 0x06, 0x0c, 0x71, 0x06, 0x0c, 0x01, 0x00, 0x0c,   0x99, 0x03, 0x0c, 0xd9, 0x06, 0x0c, 0xd9, 0x06, 0x0c, 0xd9, 0x06, 0x0c,   0xd9, 0x06, 0x0c, 0x99, 0x03, 0x0c, 0x01, 0x00, 0x0c, 0xff, 0xff, 0x0f,   0xfe, 0xff, 0x0f, 0x00, 0x00, 0x00, 0x00, 0x00, 0x00};
```

[Federal Register Volume 79, Number 209 (Wednesday, October 29, 2014)]
[Notices]
[Pages 64371-64372]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-25716]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Advanced Scientific Computing Advisory Committee; Meeting

AGENCY: Department of Energy, Office of Science.

ACTION: Notice of open meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Advanced Scientific 
Computing Advisory Committee (ASCAC). The Federal Advisory Committee 
Act (Pub. L. 92-463, 86 Stat. 770) requires that public notice of these 
meetings be announced in the Federal Register.

DATES: Friday, November 21, 2014; 8:30 a.m. to 4:30 p.m.; CST.

ADDRESSES: Hyatt Regency New Orleans, 601 Loyola Avenue, New Orleans, 
LA 70113.

FOR FURTHER INFORMATION CONTACT: Melea Baker, Office of Advanced 
Scientific Computing Research; U.S. Department of Energy; SC-21/
Germantown Building, 1000 Independence Avenue SW., Washington, DC 
20585-1290; Telephone (301) 903-7486.

SUPPLEMENTARY INFORMATION:
    Purpose of the Meeting: To provide advice and guidance on a 
continuing basis to the Department of Energy on scientific priorities 
within the field of advanced scientific computing research.
    Tentative Agenda Topics:

 View from Germantown
 Exascale Update

[[Page 64372]]

 New Charge--Review of Exascale Plan
 Report from the SciDAC Committee of Visitors (COV)
 Discussion and Vote on SciDAC COV Report
 Update on CORI
 Update on Workforce
 Applications Readiness Plan
 INCITE
 Public Comment (10-minute rule)

    Public Participation: The meeting is open to the public. To access 
the Ready Talk call:
    1. Dial Toll-Free Number: 1-866-740-1260 (U.S. & Canada).
    2. International participants dial: http://www.readytalk.com/intl.
    3. Enter access code 9039560, followed by ``#''.
    If you would like to file a written statement with the Committee, 
you may do so either before or after the meeting. If you would like to 
make oral statements regarding any of the items on the agenda, you 
should contact Melea Baker, (301) 903-7486 or 
(Melea.Baker@science.doe.gov). You must make your request for an oral 
statement at least 5 business days prior to the meeting. Reasonable 
provision will be made to include the scheduled oral statements on the 
agenda. The Chairperson of the Committee will conduct the meeting to 
facilitate the orderly conduct of business. Public comment will follow 
the 10-minute rule.
    Minutes: The minutes of this meeting will be available for viewing 
on the U.S. Department of Energy's Office of Advanced Scientific 
Computing Web site at http://science.energy.gov/ascr/.

    Issued at Washington, DC, on October 23, 2014.
LaTanya R. Butler,
Deputy Committee Management Officer.
[FR Doc. 2014-25716 Filed 10-28-14; 8:45 am]
BILLING CODE 6450-01-P
```
§ 510.605 Waiver of certain telehealth requirements. ( a ) *Waiver of the geographic site requirements.* Except for the geographic site requirements for a face-to-face encounter for home health certification, CMS waives the geographic site requirements of section 1834(m)(4)(C)(i)(I) through (III) of the Act for episodes being tested in the CJR model, but only for services that— ( 1 ) May be furnished via telehealth under existing requirements; and
( 2 ) Are included in the episode in accordance with § 510.200(b).
( b ) *Waiver of the originating site requirements.* Except for the originating site requirements for a face-to-face encounter for home health certification, CMS waives the originating site requirements under section 1834(m)(4)(C)(ii)(I) through (VIII) of the Act for episodes being tested in the CJR model to permit a telehealth visit to originate in the beneficiary's home or place of residence, but only for services that— ( 1 ) May be furnished via telehealth under existing requirements; and
( 2 ) Are included in the CJR episode in accordance with § 510.200(b).
( c ) *Waiver of selected payment provisions.* ( 1 ) CMS waives the payment requirements under section 1834(m)(2)(A) so that the facility fee normally paid by Medicare to an originating site for a telehealth service is not paid if the service is originated in the beneficiary's home or place of residence.
( 2 ) CMS waives the payment requirements under section 1834(m)(2)(B) of the Act to allow the distant site payment for telehealth home visit HCPCS codes unique to this model.
( d ) *Other requirements.* All other requirements for Medicare coverage and payment of telehealth services continue to apply, including the list of specific services approved to be furnished by telehealth.
[80 FR 73540, Nov. 24, 2015, as amended at 82 FR 57104, Dec. 1, 2017]
Editorial Note on Part 150
Editorial Note: Nomenclature changes to part 150 appear at 68 FR 14339, Mar. 25, 2003.

§ 150.1 Definitions. ( a ) *Director* means the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (*see* § 1.9(j)).
( b ) *Foreign government* means the duly-constituted executive of a foreign nation, or an international or regional intergovernmental organization which has been empowered by its member states to request issuance of Presidential proclamations on their behalf under this part.
( c ) *Interim order* means an order issued by the Secretary of Commerce under 17 U.S.C. 914.
( d ) *Mask work* means a series of related images, however fixed or encoded— ( 1 ) Having or representing the predetermined, three-dimensional pattern of metallic, insulating, or semiconductor material present or removed from the layers of a semiconductor chip product; and
( 2 ) In which series the relation of the images to one another is that each image has the pattern of the surface of one form of the semiconductor chip product.
( e ) *Presidential proclamation* means an action by the President extending to foreign nationals, domiciliaries and sovereign authorities the privilege of applying for registrations for mask works pursuant to 17 U.S.C. 902.
( f ) *Request* means a request by a foreign government for the issuance of a Presidential proclamation.
( g ) *Proceeding* means a proceeding to issue an interim order extending protection to foreign nationals, domiciliaries and sovereign authorities under 17 U.S.C. Chapter 9.
( h ) *Secretary* means the Secretary of Commerce.
[53 FR 24447, June 29, 1988, as amended at 68 Fr 14339, Mar. 25, 2003]
110TH CONGRESS 

1ST SESSION H. R. 2127 

AN ACT 

To designate the facility of the United States Postal Service 

located at 408 West 6th Street in Chelsea, Oklahoma, 

as the ‘‘Clem Rogers McSpadden Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 2127 EH

1 SECTION 1. CLEM ROGERS MCSPADDEN POST OFFICE 

2 BUILDING. 

3 (a) DESIGNATION.—The facility of the United States 

4 Postal Service located at 408 West 6th Street in Chelsea, 

5 Oklahoma, shall be known and designated as the ‘‘Clem 

6 Rogers McSpadden Post Office Building’’. 

7 (b) REFERENCES.—Any reference in a law, map, reg8 ulation, document, paper, or other record of the United 

9 States to the facility referred to in subsection (a) shall 

10 be deemed to be a reference to the ‘‘Clem Rogers 

11 McSpadden Post Office Building’’. 

Passed the House of Representatives June 18, 2007. 

Attest: 

Clerk. 

110TH CONGRESS 

1ST SESSION H. R. 2127 

AN ACT 

To designate the facility of the United States PostMcSpadden Post Office Building’’. Chelsea, Oklahoma, as the ‘‘Clem Rogers al Service located at 408 West 6th Street in